Hydrocortisone-RGD polypeptide conjugate, and preparation method and application thereof

A hydrocortisone and conjugate technology, applied in the field of biomedicine, can solve the problems of difficulty in permeating through biological membranes, poor lipid solubility, low bioavailability, etc., and achieve reduced osteoporosis side effects, excellent immunosuppression, Excellent anti-inflammatory effect

Active Publication Date: 2013-04-03
SHANDONG HUBBLE KISEN BIOLOGICAL TECH CO LTD
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After the 1980s, the discovery and application of effective immunosuppressants such as cyclosporin A and FK506 further prolong the survival time of transplante

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hydrocortisone-RGD polypeptide conjugate, and preparation method and application thereof
  • Hydrocortisone-RGD polypeptide conjugate, and preparation method and application thereof
  • Hydrocortisone-RGD polypeptide conjugate, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1 Preparation of Boc-Arg (NO 2 )-Gly-OBzl

[0036] 800mg (2.5mmol) Boc-Arg (NO 2 )-OH was dissolved in an appropriate amount of anhydrous THF, and anhydrous THF solution of 338 mg (2.5 mmol) HOBt and 619 mg (3.0 mmol) DCC was added under ice cooling. After 20 minutes of reaction, the corresponding active ester was obtained, which was directly used in the following reaction.

[0037] 775mg (2.3mmol) Tos·Gly-OBzl and 230mg (2.3mmol) N-methylmorpholine were miscible with an appropriate amount of anhydrous THF, added to the above reaction solution, and reacted at room temperature for 24 hours. TLC (CH 2 Cl 2 :MeOH=20:1) shows that the raw material point disappears. Spin to dry the solvent, add 150ml ethyl acetate, wash with saturated NaHCO 3 30ml×3, saturated sodium chloride aqueous solution 30ml×3, saturated KHSO 4 30ml×3, after washing with saturated aqueous sodium chloride solution 30ml×3, the ethyl acetate layer was washed with anhydrous NaCl 2 SO 4Dry ...

Embodiment 2

[0038] Example 2 Preparation of Boc-Arg (NO 2 )-Gly

[0039] 1.167g (2.5mmol) Boc-Arg (NO 2 )-Gly-OBzl dissolved in an appropriate amount of anhydrous CH 3 OH, add 2.5ml (5mmol) 2N NaOH aqueous solution under ice-cooling. Reacted for 30 minutes, TLC (CH 2 Cl 2 :MeOH=20:1) shows that the raw material point disappears, add saturated KHSO 4 Adjust pH-7, spin dry methanol, add saturated KHSO 4 Adjust pH-2, extract with ethyl acetate, wash the ethyl acetate layer with anhydrous Na 2 SO 4 Dried, filtered and spin-dried to obtain 1.075g, the yield (90%) was directly used in the following reaction.

Embodiment 3

[0040] Example 3 Preparation of Boc-Ser(Bzl)-OBzl

[0041] 739mg (2.5mmol) Boc-Ser(Bzl)-OH was dissolved in 10ml absolute ethanol, and 405mg (1.25mmol) Cs was added 2 CO 3 The aqueous solution was reacted at room temperature for 15 minutes, and TLC (ethyl acetate:petroleum ether=1:1) showed that the starting point disappeared. Concentrate under reduced pressure to remove the solvent to obtain the corresponding cesium salt Boc-Ser(Bzl)OCs. The obtained cesium salt was first dissolved in 2 ml of anhydrous DMF, and then 0.3 ml (2.5 mmol) of benzyl bromide was added thereto. The reaction mixture was stirred at 55-60 ° C for 4 h, TLC (CHCl 3 :MeOH=30:1) shows that the cesium salt of Boc-Ser(Bzl) disappears. The reaction mixture was concentrated to dryness under reduced pressure, the residue was dissolved in ethyl acetate, and the insoluble matter was filtered off. The filtrate was successively washed with saturated NaHCO 3 30ml×3 and 30ml×3 saturated aqueous sodium chloride s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a hydrocortisone-RGD polypeptide conjugate shown in a general formula i, and a preparation method and application thereof. In the general formula i, RGDX is tetrapeptide Arg-Gly-Asp-X, and X is any one of three amino acids of Val, Phe and Ser. Experiments prove that the compound provided by the invention has excellent immunological suppression effect and anti-inflammatory effect and the side effect of osteoporosis is reduced. The compound can be clinically used as an immunological suppressant and anti-inflammatory agent having low side effect of osteoporosis. Meanwhile, the hydrocortisone-RGD polypeptide conjugate can form nano spheres having a stable particle diameter of 200-700 nm through self assembly in a water solution. Thus, the hydrocortisone-RGD polypeptide conjugate can be prepared into an immunological suppression pharmacosome, microemulsion or liposome targeted medicament.

Description

technical field [0001] The invention relates to a hydrocortisone-RGD polypeptide conjugate, a preparation method and application thereof, and belongs to the field of biomedicine. Background technique [0002] Thousands of years ago, people had imagined replacing diseased organ tissue with normal organ tissue, but most of the transplants before the 20th century failed except for corneal transplantation. Until the 1940s, British surgeon Mdewaar used the experimental model of rabbit skin transplantation to demonstrate for the first time that rejection in organ tissue transplantation is essentially an immune response, thus laying the foundation for transplantation immunology. After the 1980s, the discovery and application of effective immunosuppressants such as cyclosporin A and FK506 further prolong the survival time of transplanted organs. However, there are some shortcomings such as biofilm, so it is urgent to study pharmaceutical nano-packaging materials to improve these sh...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K5/11C07K1/06C07K1/02A61K38/07A61P37/06A61P29/00
Inventor 彭师奇赵明梅升辉闫庆连
Owner SHANDONG HUBBLE KISEN BIOLOGICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap